RANBAXY MALAYSIA SDN BHD, today is one of the leading pharmaceutical companies in Malaysia, ranked among the top 10 branded generic companies in the country. Over the past four decades, we have been serving the healthcare community by providing high quality medicines.

Ever since the merger of Sun Pharma with Ranbaxy in 2015, the strength of our global resources have enabled us to establish a stronger presence in terms our product portfolio, R&D capabilities and reach.

With focus on therapies like Cardiology, Diabetology and Anti-infectives, we offer over 40 products in Malaysia, and we are continuously expanding our product offerings in order to meet the ever-changing needs of the community.

Our ability to improve the well-being of Malaysians is further enhanced by our state-of-the-art manufacturing plant. Located in Sungai Petani, Kedah, our plant produces over one billion doses of medicine each year for various markets in the region. Operational since 1987, our plant employs a high degree of automation, and complies with international standards with its world-class design, equipment and operations – it is WHO-GMP and PIC/s compliant, and ISO certified.

Our focus on quality is well-recognized by Malaysians. We have received accolades including Malaysian Pharmaceutical Company of the Year by Frost & Sullivan, and the Top 10 Pharmaceutical Companies Award.

We are driven by our core values of reliability, quality, innovation, trust and consistency. These values inspire us to deliver on our vision: “Reaching people and touching lives globally as a leading provider of valued medicines.”